MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom

Details for Australian Patent Application No. 2001292631 (hide)

Owner Kufe, D.W. Ohno, T.

Inventors Kufe, Donald W; Ohno, Tsuneya

Agent Pizzeys

Pub. Number AU-B-2001292631

PCT Pub. Number WO02/22685

Priority 60/231,841 11.09.00 US

Filing date 11 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 19 April 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

19 April 2007 Application Accepted

  Published as AU-B-2001292631

3 January 2008 Assignment before Grant

  Ohno, Tsuneya; Kufe, Donald W. The application has been assigned to Dana-Farber Cancer Institute, Inc.; Genzyme Corporation 2002

10 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001292632

2001292630-IMPROVED GELATINOUS ELASTOMER